Implementing Treatment Guidelines for Type 2 Diabetes in Primary Care

被引:6
作者
Brunton, Stephen [1 ]
机构
[1] Univ N Carolina, Chapel Hill, NC USA
关键词
diabetes mellitus; type; 2; insulin analogs; oral antidiabetic drugs; primary health care; treatment guidelines; patient education; TO-TARGET TRIAL; COMPARING INSULIN DETEMIR; GLUCOSE-LOWERING DRUGS; GLYCEMIC CONTROL; NPH INSULIN; CONSENSUS STATEMENT; BLOOD-GLUCOSE; NAIVE PEOPLE; LIFE-STYLE; ADD-ON;
D O I
10.3810/pgm.2009.03.1985
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The task of managing the ever-growing problem of type 2 diabetes falls mainly to primary care physicians. The currently available guidelines from the American Diabetes Association and the American College of Endocrinology/American Association of Clinical Endocrinologists aim to improve glycemic control, thus reducing morbidity and mortality associated with this chronic and progressive disease. However, the guidelines differ markedly in focus and depth. This review provides a clear summary of the guidelines and recommends how they can be implemented at the primary care level, explaining the different treatment options and providing practical advice on how commonly encountered situations should be approached in clinical practice. There is also a troubleshooting section on how to overcome obstacles to optimum therapy, and details oil implementation strategies that will encourage the aggressive, stringent, and patient-centered, treat-to-target approach recommended in the guidelines.
引用
收藏
页码:125 / 138
页数:14
相关论文
共 55 条
  • [1] Standards of medical care in diabetes 2008
    不详
    [J]. DIABETES CARE, 2008, 31 : S12 - S54
  • [2] Efficacy and safety of incretin therapy in type 2 diabetes - Systematic review and meta-analysis
    Amori, Renee E.
    Lau, Joseph
    Pittas, Anastassios G.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (02): : 194 - 206
  • [3] [Anonymous], GLOB GUID TYP 2 DIAB
  • [4] [Anonymous], 2007, National Diabetes Fact Sheet
  • [5] Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes
    Aschner, Pablo
    Kipnes, Mark S.
    Lunceford, Jared K.
    Sanchez, Matilde
    Mickel, Carolyn
    Williams-Herman, Debora E.
    [J]. DIABETES CARE, 2006, 29 (12) : 2632 - 2637
  • [6] High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men -: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study
    Balkau, B
    Shipley, M
    Jarrett, RJ
    Pyörälä, K
    Pyörälä, M
    Forhan, A
    Eschwège, E
    [J]. DIABETES CARE, 1998, 21 (03) : 360 - 367
  • [7] Blonde Lawrence, 2006, Endocr Pract, V12 Suppl 1, P131
  • [8] Systematic review: Comparative effectiveness and safety of oral medications for type 2 diabetes Mellitus
    Bolen, Shari
    Feldman, Leonard
    Vassy, Jason
    Wilson, Lisa
    Yeh, Hsin-Chieh
    Marinopoulos, Spyriclon
    Wiley, Crystal
    Selvin, Elizabeth
    Wilson, Renee
    Bass, Eric B.
    Brancati, Frederick L.
    [J]. ANNALS OF INTERNAL MEDICINE, 2007, 147 (06) : 386 - 399
  • [9] Income-related differences in the use of evidence-based therapies in older persons with diabetes mellitus in for-profit managed care
    Brown, AF
    Gross, AG
    Gutierrez, PR
    Jiang, LH
    Shapiro, MF
    Mangione, CM
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2003, 51 (05) : 665 - 670
  • [10] BRUNTON S, 2006, SUPPL J FAM PRAC DEC, P10